Where Is the Real Value in Valeant's Business?

David Amsellem, senior research analyst at Piper Jaffray & Co., and Bloomberg's Zach Tracer examine the move by Valeant Pharmaceutical to replace Chief Executive Officer Michael Pearson and the issues facing the company going forward. They speak on "Bloomberg ‹GO›." (Source: Bloomberg)

Tough Mudder Founder Explains its Popularity
33:35 - Will Dean, Tough Mudder founder and CEO, discusses why his company's events are popular, what's next in his growth strategy, and what advice he has for entrepreneurs. (Source: Bloomberg)
  • Informa's Ader Says Markets Have Lost Patience With Trump
  • What to Expect From Draghi at Jackson Hole
  • Milton Berg Makes the Case for a 30-Year Bear Market